Enlivex Therapeutics ROE - Return on Equity 2013-2024 | ENLV
Enlivex Therapeutics roe - return on equity from 2013 to 2024. Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.